Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥7,055,568 | CN¥6,629,239 | CN¥7,560,137 | CN¥4,551,984 |
| - Cash | CN¥669,373 | CN¥753,869 | CN¥853,677 | CN¥917,671 |
| + Debt | CN¥483,990 | CN¥366,387 | CN¥458,869 | CN¥413,917 |
| Enterprise Value | CN¥6,870,184 | CN¥6,241,757 | CN¥7,165,329 | CN¥4,048,230 |
| Revenue | CN¥571,785 | CN¥638,321 | CN¥721,919 | CN¥858,069 |
| % Growth | -10.4% | -11.6% | -15.9% | – |
| Gross Profit | CN¥208,455 | CN¥244,755 | CN¥246,714 | CN¥344,347 |
| % Margin | 36.5% | 38.3% | 34.2% | 40.1% |
| EBITDA | -CN¥6,375 | CN¥12,676 | CN¥53,165 | CN¥155,345 |
| % Margin | -1.1% | 2% | 7.4% | 18.1% |
| Net Income | -CN¥11,806 | CN¥8,328 | CN¥35,055 | CN¥45,727 |
| % Margin | -2.1% | 1.3% | 4.9% | 5.3% |
| EPS Diluted | -0.031 | 0.021 | 0.09 | 0.12 |
| % Growth | -245.3% | -76.2% | -25% | – |
| Operating Cash Flow | CN¥79,814 | CN¥112,933 | -CN¥8,565 | CN¥95,470 |
| Capital Expenditures | -CN¥38,833 | -CN¥17,908 | -CN¥17,561 | -CN¥30,576 |
| Free Cash Flow | CN¥40,981 | CN¥95,025 | -CN¥26,127 | CN¥64,571 |